FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

20 results

botox
(onabotulinumtoxinA)
Allergan, Inc.
Usage: BOTOX is indicated for treating overactive bladder, detrusor overactivity in adults and pediatric patients, chronic migraines, spasticity, cervical dystonia, severe primary axillary hyperhidrosis, and blepharospasm/strabismus. It is prescribed for patients unresponsive to or intolerant of anticholinergic medications. Limitations in efficacy for specific conditions are noted.
gemtesa
(vibegron)
Sumitomo Pharma America, Inc.
Usage: GEMTESA® is indicated for the treatment of overactive bladder (OAB) in adults, characterized by urge urinary incontinence, urgency, and urinary frequency. It is also indicated for adult males with OAB symptoms who are undergoing pharmacological therapy for benign prostatic hyperplasia (BPH).
mirabegron
(mirabegron)
Lupin Pharmaceuticals, Inc.
Usage: Mirabegron extended-release tablets are indicated for the treatment of adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency. Pediatric use is noted but not included in the labeling due to marketing exclusivity rights.
myrbetriq
(mirabegron)
Astellas Pharma US, Inc.
Usage: MYRBETRIQ is indicated for treating adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency, either alone or with solifenacin succinate. It is also indicated for pediatric patients (ages 3+) with neurogenic detrusor overactivity (NDO) who weigh 35 kg or more.
oxybutynin chloride
(OXYBUTYNIN CHLORIDE)
Chartwell RX, LLC
Usage: Oxybutynin chloride extended-release tablets are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. They are also approved for pediatric patients aged 6 and older with detrusor overactivity linked to neurological conditions, such as spina bifida.
oxybutynin chloride
(Oxybutynin Chloride)
Ajanta Pharma USA Inc.
Usage: Oxybutynin chloride is indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. It is also approved for pediatric patients aged 6 and older with detrusor overactivity related to neurological conditions, such as spina bifida.
oxybutynin chloride
(Oxybutynin Chloride)
Advagen Pharma Limited
Usage: Oxybutynin chloride is indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. It is also approved for pediatric patients aged 6 and older with detrusor overactivity associated with neurological conditions such as spina bifida.
oxybutynin chloride
(oxybutynin chloride)
Accord Healthcare, Inc.
Usage: Oxybutynin chloride extended-release tablets are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. They are also indicated for pediatric patients aged 6 and older with detrusor overactivity related to neurological conditions.
oxybutynin chloride
(Oxybutynin Chloride)
Upsher-Smith Laboratories, LLC
Usage: Oxybutynin chloride tablets are indicated for relieving bladder instability symptoms in patients with uninhibited or reflex neurogenic bladder, including urgency, frequency, urinary leakage, urge incontinence, and dysuria.
solifenacin succinate
(solifenacin succinate)
Ajanta Pharma USA Inc.
Usage: Solifenacin succinate tablets are indicated for treating adults with overactive bladder symptoms, including urge urinary incontinence, urgency, and urinary frequency.

Medications for Overactive Bladder

botox

gemtesa

mirabegron

myrbetriq

oxybutynin chloride

oxybutynin chloride

oxybutynin chloride

oxybutynin chloride

oxybutynin chloride

solifenacin succinate